Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: Relevance to animal models of antipsychotic drugs

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

Recent advances in the phencyclidine model of schizophrenia

1991 • 2,886 citations

Glutamate Receptor Dysfunction and Schizophrenia

1995 • 1,682 citations

The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

1999 • 1,300 citations

Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs

1989 • 1,235 citations

NMDA receptor hypofunction model of schizophrenia

1999 • 1,007 citations

Serotonin receptors : their key role in drugs to treat schizophrenia

2003 • 759 citations

Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine

1992 • 477 citations

Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy

2003 • 464 citations

New Oxford Textbook of Psychiatry

2000 • 434 citations

Nucleus Accumbens Dopamine and the Regulation of Effort in Food-Seeking Behavior: Implications for Studies of Natural Motivation, Psychiatry, and Drug Abuse

2003 • 419 citations

Delayed-Onset Hypothesis of Antipsychotic Action

2003 • 401 citations

Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon

2000 • 398 citations

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

2003 • 390 citations

New Oxford Textbook of Psychiatry

2012 • 383 citations

Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine

2005 • 314 citations

Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.

1986 • 309 citations

The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine

2004 • 244 citations

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

1982 • 238 citations

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1995 • 222 citations

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

1997 • 216 citations

Early-Onset Hypothesis of Antipsychotic Drug Action: A Hypothesis Tested, Confirmed and Extended

2005 • 215 citations

Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of Treatment

2005 • 197 citations

Dissociation between In Vivo Occupancy and Functional Antagonism of Dopamine D2 Receptors: Comparing Aripiprazole to Other Antipsychotics in Animal Models

2005 • 195 citations

Phencyclidine in the Social Interaction Test: An Animal Model of Schizophrenia with Face and Predictive Validity

1999 • 161 citations

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamine

1995 • 139 citations

Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5‐HT_2A sites for PCP‐induced locomotion in the rat

1999 • 136 citations

Time Course for Antipsychotic Treatment Response in First-Episode Schizophrenia

2006 • 130 citations

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

1995 • 121 citations

The "delayed onset" of antipsychotic action--an idea whose time has come and gone.

2006 • 106 citations

A Test of the Predictive Validity of Animal Models of Schizophrenia Based on Phencyclidine and D-Amphetamine

1998 • 102 citations

Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity

1996 • 100 citations

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity

1993 • 98 citations

Dissimilar patterns of degeneration in brain following four different addictive stimulants

1993 • 95 citations

Competitive and noncompetitive NMDA antagonists induce similar limbic degeneration

1994 • 95 citations

The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs

1987 • 92 citations

The effects of the 5-HT2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists

2006 • 92 citations

S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a Preferential Dopamine D₃ versus D₂ Receptor Antagonist and Potential Antipsychotic Agent: III. Actions in Models of Therapeutic Activity and Induction of Side Effects

2007 • 80 citations

Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague–Dawley rats: A locomotor activity and gene induction study

2007 • 74 citations

Time Course of the Antipsychotic Effect and the Underlying Behavioral Mechanisms

2006 • 67 citations

Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: Contrast with haloperidol and chlordiazepoxide

2008 • 51 citations

Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.

1984 • 51 citations

Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats

2001 • 49 citations

Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration.

2001 • 47 citations

Blockade of serotonin 5-HT 1B and 5-HT 2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes

2003 • 43 citations

Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases

2004 • 41 citations

Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction

1999 • 40 citations

Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats

1991 • 33 citations

Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic

2007 • 32 citations

Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats

2007 • 28 citations

Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity

1999 • 26 citations

The anxiolytic effect on the fear-potentiated startle is not due to a non-specific disruption

1998 • 19 citations

Olanzapine and JL13 induce cross-tolerance to the clozapine discriminative stimulus in rats

2007 • 19 citations

Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction

2000 • 18 citations

Early onset of treatment effects with oral risperidone

2007 • 16 citations

Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas

2005 • 13 citations

Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia

2006 • 8 citations